Cargando…

Tocilizumab, Adipokines and Severe Complications of COVID-19

Detalles Bibliográficos
Autores principales:	Fioravanti, Antonella, Porcelli, Brunetta, Terzuoli, Lucia, Bacarelli, Maria Romana, Tenti, Sara, Cheleschi, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357265/ https://www.ncbi.nlm.nih.gov/pubmed/32661912 http://dx.doi.org/10.1007/s40261-020-00950-2

Ejemplares similares

Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Liu, Bin, et al.
Publicado: (2020)

Exploring the Crosstalk between Hydrostatic Pressure and Adipokines: An In Vitro Study on Human Osteoarthritic Chondrocytes
por: Cheleschi, Sara, et al.
Publicado: (2021)

MiR-214-3p, a novel possible therapeutic target for the pathogenesis of osteoarthritis
por: Fioravanti, Antonella, et al.
Publicado: (2021)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Aromatase Inhibitors—Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects
por: Tenti, Sara, et al.
Publicado: (2020)

New Trends in Injection-Based Therapy for Thumb-Base Osteoarthritis: Where Are We and where Are We Going?
por: Tenti, Sara, et al.
Publicado: (2021)

Editorial: Year 2020: New Trends in Pharmacological Treatments for Osteoarthritis
por: Fioravanti, A., et al.
Publicado: (2022)

A Combination of Celecoxib and Glucosamine Sulfate Has Anti-Inflammatory and Chondroprotective Effects: Results from an In Vitro Study on Human Osteoarthritic Chondrocytes
por: Cheleschi, Sara, et al.
Publicado: (2021)

An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis
por: Tenti, Sara, et al.
Publicado: (2023)

Synovial Fluid Regulates the Gene Expression of a Pattern of microRNA via the NF-κB Pathway: An In Vitro Study on Human Osteoarthritic Chondrocytes
por: Cheleschi, Sara, et al.
Publicado: (2022)

Prescription-grade crystalline glucosamine sulfate as an add-on therapy to conventional treatments in erosive osteoarthritis of the hand: results from a 6-month observational retrospective study
por: Tenti, Sara, et al.
Publicado: (2022)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab
por: Mandal, M., et al.
Publicado: (2022)

Could Oxidative Stress Regulate the Expression of MicroRNA-146a and MicroRNA-34a in Human Osteoarthritic Chondrocyte Cultures?
por: Cheleschi, Sara, et al.
Publicado: (2017)

Hydrostatic Pressure Regulates Oxidative Stress through microRNA in Human Osteoarthritic Chondrocytes
por: Cheleschi, Sara, et al.
Publicado: (2020)

MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-κB Pathway
por: Cheleschi, Sara, et al.
Publicado: (2019)

Assessment of a combination screening assay for celiac disease
por: Porcelli, Brunetta, et al.
Publicado: (2011)

Erratum to: Assessment of a combination screening assay for celiac disease
por: Porcelli, Brunetta, et al.
Publicado: (2011)

Celiac and non-celiac gluten sensitivity: a review on the association with schizophrenia and mood disorders
por: Porcelli, Brunetta, et al.
Publicado: (2014)

A Complex Relationship between Visfatin and Resistin and microRNA: An In Vitro Study on Human Chondrocyte Cultures
por: Cheleschi, Sara, et al.
Publicado: (2018)

MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes
por: Cheleschi, Sara, et al.
Publicado: (2019)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Statistical models to predict clinical outcomes with anakinra vs. tocilizumab treatments for severe pneumonia in COVID19 patients
por: Piconi, Stefania, et al.
Publicado: (2023)

A comprehensive analysis to understand the mechanism of action of balneotherapy: why, how, and where they can be used? Evidence from in vitro studies performed on human and animal samples
por: Cheleschi, Sara, et al.
Publicado: (2020)

High levels of TNFα in patients with COVID-19 refractory to tocilizumab
por: Danlos, F.X., et al.
Publicado: (2021)

Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021)

Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Italian and Japanese public attention toward balneotherapy in the COVID-19 era
por: Maccarone, Maria Chiara, et al.
Publicado: (2021)

Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19
por: Gade, Akhil R., et al.
Publicado: (2020)

Risk of hepatitis B reactivation following baricitinib or tocilizumab for treatment of COVID-19
por: Foo, Hong, et al.
Publicado: (2023)

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
por: Kow, C.S., et al.
Publicado: (2021)

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply
por: Cortegiani, A., et al.
Publicado: (2021)

Efficacy of tocilizumab treatment in severely ill COVID-19 patients
por: Zhao, Jie, et al.
Publicado: (2020)

Possible synergic action of non-steroidal anti-inflammatory drugs and glucosamine sulfate for the treatment of knee osteoarthritis: a scoping review
por: Veronese, Nicola, et al.
Publicado: (2022)

Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia
por: Gokhale, Yojana, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)

Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2022)

Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qlivp8c8vq7v9g4210ktv9gvv7